SUBSCRIBE
SUBSCRIBE
News   Drug Development

Anavex Life Sciences Corp. Announces Its Preclinical Pipeline Of Novel Oncology Therapies

February 12, 2007 | 
1 min read
KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- February 12, 2007 -- Anavex Life Sciences Corp. (the "Company") (OTCBB: AVXL) announces its strategic vision for growth by discovering and developing cutting-edge drugs against solid tumors.
Preclinical
Anavex Life Sciences Corp.
MORE ON THIS TOPIC
Sorting garbage concept. Cropped photo of paper thash. Crumple paper falling to the recycling bin
Drug Development
Genmab drops 2 antibody assets, including another ProfoundBio ADC
May 15, 2026
 · 
2 min read
 · 
Gabrielle Masson
Brain shaped maze. Conceptual image of science and medicine. 3D illustration.
Drug Development
Biogen’s Alzheimer’s results bolster tau theory—and Denali’s next gen candidate
May 15, 2026
 · 
3 min read
 · 
Annalee Armstrong
A vibrant geometric pattern of colorful book spines arranged neatly on shelves. This texture represents organized knowledge and information storage. The minimalist composition and bright colors are ideal for educational, corporate, or creative graphic design projects.
Insights
GPCRs, radiopharma and the rise of functional peptide screening
May 14, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker
Lightbulb with tangled lines. Problem solving and brainstorming Idea concept. Vector illustration
Gene therapy
REGENXBIO slumps after serious side effects mar Duchenne gene therapy results
May 14, 2026
 · 
3 min read
 · 
Annalee Armstrong